leisure time -WSS

leisure time

author：Wikipedia 2025-10-01 13:59:13 - browse：9484

The sign of University of Texas MD Anderson Cancer Center in Houston, Texas in front of the Sheikh Zayed Building — coverage from STAT — Adobe

Early last year, MD Anderson Cancer Center leadership had a problem on their hands: a contentious dispute between one of its most powerful researchers and a junior scientist over authorship, credit, and charges of verbal abuse. High-ranking officials at the cancer center tried — and failed — to resolve the feud, and documents obtained by STAT shed new light on the deep divisions at the heart of this case.

The Texas cancer center outsourced assessing the conflict between early-career nephrologist Jamie Lin and leading oncologist Padmanee Sharma to the law firm Ropes & Gray. The firm investigated the authorship and scientific credit portions of the dispute and concluded that Sharma was likely responsible for a scientific hypothesis at the heart of the feud and should be named as a co-senior author on a key manuscript.

But a separate investigation, commissioned by Lin and conducted by a former official at the federal Office of Research Integrity, tells a somewhat different story. That review looked into plagiarism after Sharma claimed Lin had wrongly omitted the senior researcher as an author from a manuscript built on research to which Sharma contributed. But this second investigation found no evidence of plagiarism between two manuscripts submitted to the journals Cancer Immunology Research and Journal of Clinical Investigation Insight.

Lin provided STAT with copies of an executive summary of the Ropes & Gray investigation as well as the conclusions of the plagiarism investigation. These documents are alluded to in legal filings but have not been previously reported. Lin has filed a lawsuit against Sharma in the Harris County District Court alleging retaliation, harassment, threatening, and intellectual theft by Sharma; she’s also asking for $5 million in damages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Apple is now the first public company to be valued at $3 trillion

WSS

DIEP, the 'gold standard' of breast reconstruction, is under threat

Novavax promises a turnaround & Lilly roils the obesity market

Why the advice to take all your antibiotics may be wrong

Pfizer's RSV vaccine recommended for approval in Europe

Reframing the conversation around gain

Heart attack and stroke risk calculators need revising

explore

leisure time

focus

Bright Health sells Medicare Advantage business to Molina

How to save PrEP access — and even expand it

New air purifier tech could be key to improving indoor air quality

Biden White House, tech companies launch new safeguards around emerging AI technology

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Supreme Court strikes down use of affirmative action

Anesthesiologist group: stop taking Ozempic before surgery

Walensky prepares to leave CDC — and Congress — behind

The high cost of giving birth even with insurance

Washington Commanders' Dan Snyder ordered to pay NFL $60M following investigation

focus

How to save PrEP access — and even expand it

Anesthesiologist group: stop taking Ozempic before surgery

Prosecutors say FTX founder Sam Bankman

Novavax promises a turnaround & Lilly roils the obesity market

Sports medicine is finally prioritizing gender equality

The biotech scorecard for the 2nd quarter: 12 industry events to watch

explore

Wikipedia

entertainment

focus